| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combined liquid Hib (PRP-OMP), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: uncontrolled preliminary clinical trial of immunogenicity and reactogenicity
|
Nolan, Terry
|
|
1998
|
16 |
20 |
p. 2085-2089
5 p.
|
artikel
|
| 2 |
A model to estimate the potential economic benefits of measles eradication for the United States
|
Miller, Mark A.
|
|
1998
|
16 |
20 |
p. 1917-1922
6 p.
|
artikel
|
| 3 |
Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines
|
Eyles, Jim E.
|
|
1998
|
16 |
20 |
p. 2000-2009
10 p.
|
artikel
|
| 4 |
Anti-haemolysin IgG1 to IgG2 ratios correlate with haemolysin neutralization titres and lung lesion scores in Actinobacillus pleuropneumoniae infected pigs
|
Furesz, S.E
|
|
1998
|
16 |
20 |
p. 1971-1975
5 p.
|
artikel
|
| 5 |
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
|
Cherry, James D
|
|
1998
|
16 |
20 |
p. 1901-1906
6 p.
|
artikel
|
| 6 |
Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age
|
Arístegui, Javier
|
|
1998
|
16 |
20 |
p. 1976-1981
6 p.
|
artikel
|
| 7 |
Delayed progression of murine AIDS in C57BL 6 mice pre-immunized with a highly antigenic 10-mer peptide encoded by the murine AIDS defective virus gag p12 gene
|
Mizuochi, Toshiaki
|
|
1998
|
16 |
20 |
p. 2026-2030
5 p.
|
artikel
|
| 8 |
Duration of serum antibody responses following vaccination and revaccination of cattle with non-living commercial Pasteurella haemolytica vaccines
|
Confer, A.W
|
|
1998
|
16 |
20 |
p. 1962-1970
9 p.
|
artikel
|
| 9 |
Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A
|
Thompson, H.S.G
|
|
1998
|
16 |
20 |
p. 1993-1999
7 p.
|
artikel
|
| 10 |
Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine
|
Koike, Yuko
|
|
1998
|
16 |
20 |
p. 1982-1989
8 p.
|
artikel
|
| 11 |
Fluorescence spectroscopy monitoring of the conformational restraint of formaldehyde- and glutaraldehyde- treated infectious bursal disease virus proteins
|
Cepica, Arnost
|
|
1998
|
16 |
20 |
p. 1957-1961
5 p.
|
artikel
|
| 12 |
Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells — effects of passage in cell culture and the human gastrointestinal tract
|
Chezzi, C.
|
|
1998
|
16 |
20 |
p. 2031-2038
8 p.
|
artikel
|
| 13 |
Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis
|
Swartz, Tiberio Alex
|
|
1998
|
16 |
20 |
p. 2090-2095
6 p.
|
artikel
|
| 14 |
Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers
|
Kumar, Mary L.
|
|
1998
|
16 |
20 |
p. 2047-2051
5 p.
|
artikel
|
| 15 |
Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response
|
Rodriguez, María E.
|
|
1998
|
16 |
20 |
p. 1941-1949
9 p.
|
artikel
|
| 16 |
Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use
|
Deliyannis, Georgia
|
|
1998
|
16 |
20 |
p. 2058-2068
11 p.
|
artikel
|
| 17 |
Inducing cytoxic T-lymphocyte response to HIV; recombinant vaccinia virus expressing HIV virus gp160 for use as a recombinant vaccine
|
|
|
1998
|
16 |
20 |
p. 2097-
1 p.
|
artikel
|
| 18 |
Induction of HIV-1 IIIb neutralizing antibodies in BALB c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV
|
Fernández, I.M
|
|
1998
|
16 |
20 |
p. 1936-1940
5 p.
|
artikel
|
| 19 |
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
|
Storsaeter, Jann
|
|
1998
|
16 |
20 |
p. 1907-1916
10 p.
|
artikel
|
| 20 |
Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results
|
Van Herck, Koen
|
|
1998
|
16 |
20 |
p. 1933-1935
3 p.
|
artikel
|
| 21 |
Musosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen
|
Verweij, Willem R
|
|
1998
|
16 |
20 |
p. 2069-2076
8 p.
|
artikel
|
| 22 |
New lymphocyte stimulating factor which stimulates release of interferon-gamma from CD8 cells; for use in African sleeping sickness recombinant vaccine
|
|
|
1998
|
16 |
20 |
p. 2097-
1 p.
|
artikel
|
| 23 |
New population of dendritic cell precursors with CD34Io, CD123hi phenotype; dendrite cell culture for use as vaccine
|
|
|
1998
|
16 |
20 |
p. 2097-
1 p.
|
artikel
|
| 24 |
Oral administration of polymer-grafted starch microparticles activates gut-associated lymphocytes and primes mice for a subsequent systemic antigen challenge
|
Heritage, Philippa L.
|
|
1998
|
16 |
20 |
p. 2010-2017
8 p.
|
artikel
|
| 25 |
Protection against Boophilus annulatus infestations in cattle vaccinated with the B. microplus Bm86-containing vaccine Gavac
|
Fragoso, H.
|
|
1998
|
16 |
20 |
p. 1990-1992
3 p.
|
artikel
|
| 26 |
Serological correlates of immunity to Bordetella pertussis
|
Hewlett, E.L.
|
|
1998
|
16 |
20 |
p. 1899-1900
2 p.
|
artikel
|
| 27 |
Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1
|
Hodgins, Douglas C.
|
|
1998
|
16 |
20 |
p. 2018-2025
8 p.
|
artikel
|
| 28 |
Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin
|
Hotomi, Muneki
|
|
1998
|
16 |
20 |
p. 1950-1956
7 p.
|
artikel
|
| 29 |
Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice
|
Jabbal-Gill, Inderjit
|
|
1998
|
16 |
20 |
p. 2039-2046
8 p.
|
artikel
|
| 30 |
The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines
|
Fine, Paul E.M.
|
|
1998
|
16 |
20 |
p. 1923-1928
6 p.
|
artikel
|
| 31 |
The plea against annual influenza vaccination? ‘The Hoskins' Paradox’ revisited
|
Beyer, W.E.P.
|
|
1998
|
16 |
20 |
p. 1929-1932
4 p.
|
artikel
|
| 32 |
Use of cytomegalovirus genes UBattelleS3 or US6; for use as recombinant vaccine or in immunosuppressive gene therapy
|
|
|
1998
|
16 |
20 |
p. 2097-
1 p.
|
artikel
|
| 33 |
Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection
|
Sjölander, Anders
|
|
1998
|
16 |
20 |
p. 2077-2084
8 p.
|
artikel
|
| 34 |
Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
|
Davidkin, Irja
|
|
1998
|
16 |
20 |
p. 2052-2057
6 p.
|
artikel
|
| 35 |
Vector construct directing expression of an intracellular pathogenic antigen; HIV virus, FIV virus, hepatitis B virus and hepatitis C virus for use in gene therapy and as a recombinant vaccine against bacterium and virus infection
|
|
|
1998
|
16 |
20 |
p. 2097-
1 p.
|
artikel
|
Tijdschrift beschrijving